RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 108 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 4.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $893,000 | -36.6% | 375,264 | -2.2% | 0.00% | 0.0% |
Q3 2016 | $1,408,000 | +48.4% | 383,690 | -9.8% | 0.00% | 0.0% |
Q2 2016 | $949,000 | +7.5% | 425,410 | +0.2% | 0.00% | 0.0% |
Q1 2016 | $883,000 | -29.5% | 424,427 | +2.7% | 0.00% | 0.0% |
Q4 2015 | $1,252,000 | +7.5% | 413,126 | -12.4% | 0.00% | 0.0% |
Q3 2015 | $1,165,000 | -16.2% | 471,584 | +8.9% | 0.00% | 0.0% |
Q2 2015 | $1,390,000 | -28.9% | 432,979 | -21.0% | 0.00% | -50.0% |
Q1 2015 | $1,955,000 | +57.8% | 547,753 | +0.3% | 0.00% | +100.0% |
Q4 2014 | $1,239,000 | -37.8% | 545,864 | -46.8% | 0.00% | -50.0% |
Q3 2014 | $1,992,000 | -46.0% | 1,026,590 | +1.1% | 0.00% | -33.3% |
Q2 2014 | $3,686,000 | +136.6% | 1,015,346 | +152.8% | 0.00% | +50.0% |
Q1 2014 | $1,558,000 | +821.9% | 401,666 | +578.5% | 0.00% | – |
Q4 2013 | $169,000 | -11.1% | 59,201 | +11.5% | 0.00% | – |
Q3 2013 | $190,000 | +7.3% | 53,106 | +0.4% | 0.00% | – |
Q2 2013 | $177,000 | – | 52,873 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 1,847,087 | $4,119,000 | 3.26% |
Sio Capital Management, LLC | 1,333,696 | $2,974,000 | 1.52% |
Boxer Capital, LLC | 700,000 | $1,561,000 | 1.38% |
Palo Alto Investors LP | 5,386,534 | $12,012,000 | 0.91% |
ACUTA CAPITAL PARTNERS, LLC | 747,748 | $1,667,000 | 0.80% |
SENZAR ASSET MANAGEMENT, LLC | 1,443,003 | $3,217,897,000 | 0.70% |
Ghost Tree Capital, LLC | 800,000 | $1,784,000 | 0.52% |
NEA Management Company, LLC | 3,243,150 | $7,232,000 | 0.38% |
Rhenman & Partners Asset Management AB | 850,000 | $1,896,000 | 0.34% |
Rock Springs Capital Management LP | 1,750,000 | $3,903,000 | 0.29% |